- Home
- KRMD vs HBIO Comparison
KRMD vs HBIO Comparison
Compare KRMD & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- HBIO
- Stock Information
- Founded
- KRMD 1980
- HBIO 1901
- Country
- KRMD United States
- HBIO United States
- Employees
- KRMD N/A
- HBIO N/A
- Industry
- KRMD Medical/Dental Instruments
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- KRMD Health Care
- HBIO Industrials
- Exchange
- KRMD Nasdaq
- HBIO Nasdaq
- Market Cap
- KRMD 134.3M
- HBIO 19.6M
- IPO Year
- KRMD N/A
- HBIO 2000
- Fundamental
- Price
- KRMD $3.22
- HBIO $0.43
- Analyst Decision
- KRMD Strong Buy
- HBIO Buy
- Analyst Count
- KRMD 4
- HBIO 2
- Target Price
- KRMD $4.63
- HBIO $3.00
- AVG Volume (30 Days)
- KRMD 450.7K
- HBIO 1.1M
- Earning Date
- KRMD 08-06-2025
- HBIO 08-07-2025
- Dividend Yield
- KRMD N/A
- HBIO N/A
- EPS Growth
- KRMD N/A
- HBIO N/A
- EPS
- KRMD N/A
- HBIO N/A
- Revenue
- KRMD $35,083,740.00
- HBIO $91,397,000.00
- Revenue This Year
- KRMD $18.16
- HBIO N/A
- Revenue Next Year
- KRMD $14.60
- HBIO $9.75
- P/E Ratio
- KRMD N/A
- HBIO N/A
- Revenue Growth
- KRMD 19.65
- HBIO N/A
- 52 Week Low
- KRMD $1.86
- HBIO $0.28
- 52 Week High
- KRMD $5.05
- HBIO $3.60
- Technical
- Relative Strength Index (RSI)
- KRMD 42.70
- HBIO 45.04
- Support Level
- KRMD $3.54
- HBIO $0.42
- Resistance Level
- KRMD $3.80
- HBIO $0.48
- Average True Range (ATR)
- KRMD 0.23
- HBIO 0.04
- MACD
- KRMD -0.04
- HBIO -0.01
- Stochastic Oscillator
- KRMD 7.63
- HBIO 8.15
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.